Zhejiang Hisoar Pharmaceutical Co., Ltd. (SHE:002099)
5.88
-0.03 (-0.51%)
Jun 6, 2025, 3:04 PM CST
SHE:002099 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | -353.63 | -330.27 | -420.06 | 88.01 | 95.23 | 319.72 | Upgrade
|
Depreciation & Amortization | 342.54 | 342.54 | 364.6 | 336.52 | 294.23 | 256.57 | Upgrade
|
Other Amortization | 1.79 | 1.79 | 1.17 | 0.46 | 0.26 | 0.22 | Upgrade
|
Loss (Gain) From Sale of Assets | -1.04 | -1.04 | -12.88 | -0.29 | 1.48 | -0.34 | Upgrade
|
Asset Writedown & Restructuring Costs | 242.85 | 242.85 | 132.82 | 60.16 | -0.55 | 0.99 | Upgrade
|
Loss (Gain) From Sale of Investments | 27.68 | 27.68 | 83.92 | 27.27 | -9.8 | 20.31 | Upgrade
|
Provision & Write-off of Bad Debts | 4.54 | 4.54 | -13.41 | 17.53 | 10.08 | 2.23 | Upgrade
|
Other Operating Activities | 122.4 | 152.39 | 171.89 | -36.1 | 61.59 | 76.22 | Upgrade
|
Change in Accounts Receivable | -340.3 | -340.3 | 2.74 | -229.76 | -754.98 | -353.18 | Upgrade
|
Change in Inventory | -264.23 | -264.23 | 293.73 | -213.74 | -194.08 | 102.12 | Upgrade
|
Change in Accounts Payable | 347.63 | 347.63 | -316.52 | 67.64 | 601.96 | 60.28 | Upgrade
|
Operating Cash Flow | 121.48 | 174.83 | 240.54 | 116.09 | 102.36 | 533.87 | Upgrade
|
Operating Cash Flow Growth | 10.86% | -27.32% | 107.19% | 13.41% | -80.83% | -12.82% | Upgrade
|
Capital Expenditures | -133.02 | -122.11 | -153.08 | -179.42 | -229.56 | -74.18 | Upgrade
|
Sale of Property, Plant & Equipment | 8.09 | 8.09 | 24.34 | 5.66 | 9.23 | 3.72 | Upgrade
|
Divestitures | - | - | - | - | 0.16 | - | Upgrade
|
Investment in Securities | 24 | 24 | -40.5 | -459.13 | -254 | -0.12 | Upgrade
|
Other Investing Activities | -19.41 | -437.37 | 41.03 | 12.58 | -34.84 | - | Upgrade
|
Investing Cash Flow | -120.35 | -527.39 | -128.21 | -620.32 | -509.01 | -70.58 | Upgrade
|
Short-Term Debt Issued | - | - | - | - | - | 460 | Upgrade
|
Long-Term Debt Issued | - | 2,507 | 2,307 | 2,228 | 1,069 | - | Upgrade
|
Total Debt Issued | 2,276 | 2,507 | 2,307 | 2,228 | 1,069 | 460 | Upgrade
|
Short-Term Debt Repaid | - | - | - | - | - | -230 | Upgrade
|
Long-Term Debt Repaid | - | -2,591 | -2,321 | -1,822 | -934.76 | - | Upgrade
|
Total Debt Repaid | -2,386 | -2,591 | -2,321 | -1,822 | -934.76 | -230 | Upgrade
|
Net Debt Issued (Repaid) | -109.42 | -84.56 | -14.51 | 406.11 | 134.24 | 230 | Upgrade
|
Issuance of Common Stock | - | - | - | - | - | 236.9 | Upgrade
|
Repurchase of Common Stock | -151.42 | -151.42 | - | - | - | - | Upgrade
|
Common Dividends Paid | -24.55 | -28.06 | -118.94 | -195.44 | -53.45 | -478.09 | Upgrade
|
Other Financing Activities | 335.7 | 267.5 | 232.52 | -332.55 | - | - | Upgrade
|
Financing Cash Flow | 50.31 | 3.46 | 99.07 | -121.88 | 80.79 | -11.19 | Upgrade
|
Foreign Exchange Rate Adjustments | 41.23 | 35.69 | 1.1 | 75.13 | -25.53 | -38.48 | Upgrade
|
Net Cash Flow | 92.67 | -313.4 | 212.5 | -550.97 | -351.39 | 413.62 | Upgrade
|
Free Cash Flow | -11.54 | 52.73 | 87.46 | -63.33 | -127.2 | 459.69 | Upgrade
|
Free Cash Flow Growth | - | -39.72% | - | - | - | 1.75% | Upgrade
|
Free Cash Flow Margin | -0.61% | 2.72% | 4.03% | -2.34% | -5.12% | 18.60% | Upgrade
|
Free Cash Flow Per Share | -0.01 | 0.03 | 0.05 | -0.04 | -0.08 | 0.29 | Upgrade
|
Cash Income Tax Paid | - | -36.96 | -19.73 | -88.14 | 9.28 | 1.46 | Upgrade
|
Levered Free Cash Flow | 101.22 | 237.44 | 202.78 | 77.39 | 401.47 | 723.85 | Upgrade
|
Unlevered Free Cash Flow | 117.27 | 255.44 | 226.38 | 100.23 | 415.15 | 730.96 | Upgrade
|
Change in Net Working Capital | -22.47 | -115.43 | -180.86 | 181.27 | -76.62 | -246.99 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.